San Francisco, CA, United States of America

Catherine M Strahl


Average Co-Inventor Count = 9.2

ph-index = 3

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 1997-2003

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Catherine M Strahl

Introduction

Catherine M Strahl is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the study of telomerase activity and its implications for health and disease. With a total of three patents to her name, her work has the potential to impact the treatment of various proliferative diseases.

Latest Patents

Catherine's latest patents include innovative diagnostic methods for conditions associated with elevated cellular levels of telomerase activity. These methods provide compositions for determining telomere length and telomerase activity, as well as techniques to increase or decrease telomerase activity in the treatment of proliferative diseases. The patents detail how primers can be elongated under conditions that minimize interference from other genomic sequences, ensuring accurate determinations of telomeric length or telomerase activity. Additionally, her work includes compositions for intracellular inhibition of telomerase activity and methods for slowing or reversing the loss of telomeric repeats in aging cells.

Career Highlights

Catherine has worked with esteemed institutions such as the University of Texas System and the University of California. Her research has been pivotal in advancing our understanding of telomerase and its role in cellular aging and disease.

Collaborations

Catherine has collaborated with notable figures in her field, including Michael D West and Calvin B Harley. These partnerships have further enriched her research and contributed to her innovative approaches.

Conclusion

Catherine M Strahl's work exemplifies the intersection of innovation and health science. Her patents and research continue to pave the way for advancements in the treatment of diseases related to telomerase activity.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…